Review article: potassium‐competitive acid blockers for the treatment of acid‐related disorders - Abdel‐Aziz - 2021 - Alimentary Pharmacology & Therapeutics - Wiley Online Library
Protonated Form: The Potent Form of Potassium-Competitive Acid Blockers | PLOS ONE
Acid Suppressant Therapy: a Step Forward with Potassium-Competitive Acid Blockers | SpringerLink
P cab
TAK-438 (vonoprazan) | ≥99%(HPLC) | potassium-competitive acid Blocker | AdooQ®
Chemical structure of potassium-competitive acid blockers. | Download Scientific Diagram
A comparative study on the modes of action of TAK-438, a novel potassium-competitive acid blocker, and lansoprazole in primary cultured rabbit gastric glands - ScienceDirect
Potassium-competitive acid blockers: Advanced therapeutic option for acid-related diseases - ScienceDirect
Potassium-competitive acid blockers: Advanced therapeutic option for acid-related diseases - ScienceDirect
Our Pipeline - Neurogastrx, Inc.
Potassium-competitive acid blockers, a new therapeutic class, and their role in acid-related diseases: a narrative review
Frontiers | Novel Potassium-Competitive Acid Blocker, Tegoprazan, Protects Against Colitis by Improving Gut Barrier Function
Tegoprazan, a Novel Potassium-Competitive Acid Blocker to Control Gastric Acid Secretion and Motility | Journal of Pharmacology and Experimental Therapeutics
Vonoprazan (TAK-438 free base) | Potassium-Competitive Acid Blocker | MedChemExpress
Exploring Potassium Competitive Acid Blockers (PCABs) as a Mechanism in Acid-Related GI Diseases
Potassium-competitive acid blockers and gastroesophageal reflux disease
Potassium-Competitive Acid Blockers (P-CABs): Are They Finally Ready for Prime Time in Acid-Related Disease? - Abstract - Europe PMC
American College of Gastroenterology - In the Red Journal: Pharmacodynamics and Pharmacokinetics of the Potassium-Competitive Acid Blocker Vonoprazan and the Proton Pump Inhibitor Lansoprazole in U.S. Subjects, Laine, et al. 👉 bit.ly/3au3WqZ #
Potassium Competitive Acid Blockers (P-CAB) - GIT Pharmacology - Part 4 - YouTube
Pharmaceuticals | Free Full-Text | The Potential Benefits of Vonoprazan as Helicobacter pylori Infection Therapy
Potassium-competitive acid blockers and gastroesophageal reflux disease
대웅제약 - 항궤양제 신약 DWP14012 / Potassium-competitive acid blocker (P-CAB) 또는 acid pump antagonist (APA) 계열
